Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05143840
Title Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Augusta University

chronic myeloid leukemia



Asciminib + Nilotinib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.